期刊
FUTURE MEDICINAL CHEMISTRY
卷 15, 期 16, 页码 1527-1548出版社
Newlands Press Ltd
DOI: 10.4155/fmc-2023-0138
关键词
anticancer; azole; hybrid; imidazole; isoxazole; mechanism of action; oxazole; pyrazole; structure-activity relationship; thiazole; triazole
This article highlights the recent advances in pyrazole-azole hybrids with anticancer potential, discussing the structure-activity relationships to facilitate the rational design of more effective anticancer candidates.
Chemotherapy is a critical treatment modality for cancer patients, but multidrug resistance remains one of the major challenges in cancer therapy, creating an urgent need for the development of novel potent chemical entities. Azoles, particularly pyrazole, could interact with different biological targets and exhibit diverse biological properties including anticancer activity. Many clinically used anticancer agents own an azole moiety, demonstrating that azoles are privileged and pivotal templates in the discovery of novel anticancer chemotherapeutics. The present article is an attempt to highlight the recent advances in pyrazole-azole hybrids with anticancer potential and discuss the structure-activity relationships, covering articles published from 2018 to present, to facilitate the rational design of more effective anticancer candidates.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据